πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9187516

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181530

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9180179

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9181306

Insertion of foreign genes in rubella virus and their stable expression in a live, attenua

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173886

Antiviral compounds and methods of use thereof

TRANA DISCOVERY, INC. Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9174990

2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169297

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169296

Expression and assembly of human group C rotavirus-like particles and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9168269

Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163068

Influenza virus recombinant proteins

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9163248

Targeting pseudotyped retroviral vectors

The Regents of the University of California Β· Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9156818

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9149445

Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treat

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9145548

Foot and mouth disease virus with increased stability and its use as vaccine

The Pirbright Institute Β· Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9144605

Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-depend

The Board of Regents of the University of Texas System Β· Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9139575

Broad spectrum antiviral and antiparasitic agents

The Regents of the University of California Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9139620

Feline morbillivirus and uses thereof

THE GOVERNMENT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133478

Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133462

dsRNA for treating viral infection

Arrowhead Research Corporation Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133480

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9127021

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115187

Identification of antibodies specific for lyssaviruses and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9109014

Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc

Inovio Pharmaceuticals, Inc. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9097713

Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC Β· Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted